These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12646638)

  • 1. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
    Rao S; Gerondakis S; Woltring D; Shannon MF
    J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
    Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
    J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proximal kappaB site in the IL-23 p19 promoter is responsible for RelA- and c-Rel-dependent transcription.
    Mise-Omata S; Kuroda E; Niikura J; Yamashita U; Obata Y; Doi TS
    J Immunol; 2007 Nov; 179(10):6596-603. PubMed ID: 17982049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
    J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic regulation of Il2 transcription in CD4+ T cells: roles for TNF-alpha receptor signaling and chromatin structure.
    McKarns SC; Schwartz RH
    J Immunol; 2008 Jul; 181(2):1272-81. PubMed ID: 18606681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
    Nolz JC; Fernandez-Zapico ME; Billadeau DD
    J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activation.
    Poke FS; Upcher WR; Sprod OR; Young A; Brettingham-Moore KH; Holloway AF
    PLoS One; 2012; 7(7):e41734. PubMed ID: 22860011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats.
    Gong Z; Liu T; Wan Y; Hang Z; Tong X; Zhang B; Yang H; Zhang X; Zhang L; Jin G
    Mol Immunol; 2014 Sep; 61(1):1-6. PubMed ID: 24853588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
    Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
    J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
    Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
    J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of type I diabetes by NF-kappa B.
    Lamhamedi-Cherradi SE; Zheng S; Hilliard BA; Xu L; Sun J; Alsheadat S; Liou HC; Chen YH
    J Immunol; 2003 Nov; 171(9):4886-92. PubMed ID: 14568969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
    Kalli K; Huntoon C; Bell M; McKean DJ
    Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism.
    Tenbrock K; Juang YT; Tolnay M; Tsokos GC
    J Immunol; 2003 Mar; 170(6):2971-6. PubMed ID: 12626549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel NF-kappa B/Rel site in intron 1 cooperates with proximal promoter elements to mediate TNF-alpha-induced transcription of the human polymeric Ig receptor.
    Schjerven H; Brandtzaeg P; Johansen FE
    J Immunol; 2001 Dec; 167(11):6412-20. PubMed ID: 11714807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
    Maggirwar SB; Harhaj EW; Sun SC
    Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.